Results 71 to 80 of about 56,601 (206)

BRONCHIOLITIS OBLITERANS SYNDROME SUSCEPTIBILITY AND THE PULMONARY MICROBIOME

open access: yesThe Journal of Heart and Lung Transplantation, 2018
Background Lung transplantation outcomes remain complicated by bronchiolitis obliterans syndrome (BOS), a major cause of mortality and re-transplantation for patients.
C. Schott   +6 more
semanticscholar   +1 more source

Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome

open access: yesFrontiers in Immunology, 2018
Bronchiolitis obliterans syndrome (BOS), the main manifestation of chronic lung allograft dysfunction, leads to poor long-term survival after lung transplantation.
R. Danger   +24 more
semanticscholar   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

open access: yesPediatric Blood &Cancer, Volume 73, Issue 8, August 2026.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli   +3 more
wiley   +1 more source

Non-infectious respiratory complications after allogeneic bone marrow transplantation: single center experience in Egypt

open access: yesThe Egyptian Journal of Bronchology
Background Hematopoietic progenitor cells are infused intravenously, known as hematopoietic stem cell transplantation. The range of pulmonary problems after transplantation of hematopoietic stem cells varies significantly from infectious to non ...
Mona M. Motawea   +3 more
doaj   +1 more source

From scarring to healing: Emerging regenerative therapies for pulmonary fibrosis using MSCs and exosomes

open access: yesClinical and Translational Discovery, Volume 6, Issue 4, August 2026.
MSCs exert anti‐inflammatory, anti‐fibrotic and regenerative effects in pulmonary fibrosis. MSC‐derived exosomes reproduce many therapeutic benefits of parental MSCs. Preconditioning and genetic modification improve MSC therapeutic performance. Current preclinical and clinical evidence supports the translational potential of MSC‐based therapies ...
Hajar Nasiri   +8 more
wiley   +1 more source

POSTINFECTIOUS OBLITERANS BRONCHIOLITIS IN CHILDREN [PDF]

open access: yes, 2015
Literature review describes the problem of bronchiolitis obliterans in children. The review analyzes modern date on etiology, morphological sings, clinical course, treatment and prognosis of diseas.
E. V. Boitsova, D. Yu. Ovsyannikov
core   +1 more source

Histopathological Analogies in Chronic Pulmonary Lesions between Cattle and Humans: Basis for an Alternative Animal Model

open access: yesThe Scientific World Journal, 2012
Most of the natural cases of pneumonia in feedlot cattle are characterized by a longer clinical course due to chronic lung lesions. Microscopically, these lesions include interstitial fibroplasia, bronchitis, bronchiectasis, bronchiolitis obliterans, and
Rafael Ramírez-Romero   +5 more
doaj   +1 more source

Characteristics and Progression of Rehabilitation in Patients Undergoing Extracorporeal Membrane Oxygenation: A Retrospective Study

open access: yesClinical Transplantation, Volume 40, Issue 8, August 2026.
ABSTRACT Objectives Early rehabilitation during extracorporeal membrane oxygenation (ECMO) support is increasingly implemented, yet real‐world data describing rehabilitation progression remain limited. This study aimed to characterize rehabilitation patterns during ECMO and descriptively compare physical activity trajectories among patients managed as ...
Woo Chul Son   +9 more
wiley   +1 more source

Improving survival outcomes in lung transplant recipients through early detection of bronchiolitis obliterans: Daily home spirometry versus standard pulmonary function testing [PDF]

open access: yes, 2014
Bronchiolitis obliterans syndrome (BOS) is a fibrotic inflammatory process that manifests in a significant number of lung transplant recipients within five years of transplant.
Kevin S Robson, Andrew J West
core  

LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats

open access: yesJournal of Cardiothoracic Surgery, 2017
Background Lung transplantation is the only effective treatment for end-stage lung diseases. Bronchiolitis obliterans, which is known as non-infectious chronic lung allograft dysfunction (CLAD) in the new classification, is the greatest threat to long ...
Zheng-Liang Tu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy